BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34979464)

  • 1. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.
    Wang C; Chen L; Sun Y; Guo W; Taouil AK; Ojima I
    Bioorg Chem; 2022 Feb; 119():105578. PubMed ID: 34979464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH
    Wang C; Wang X; Sun Y; Taouil AK; Yan S; Botchkina GI; Ojima I
    Bioorg Chem; 2020 Jan; 95():103523. PubMed ID: 31911305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of new-generation taxoids.
    Ojima I; Chen J; Sun L; Borella CP; Wang T; Miller ML; Lin S; Geng X; Kuznetsova L; Qu C; Gallager D; Zhao X; Zanardi I; Xia S; Horwitz SB; Mallen-St Clair J; Guerriero JL; Bar-Sagi D; Veith JM; Pera P; Bernacki RJ
    J Med Chem; 2008 Jun; 51(11):3203-21. PubMed ID: 18465846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.
    Tang Y; Rodríguez-Salarichs J; Zhao Y; Cai P; Estévez-Gallego J; Balaguer-Pérez F; Redondo Horcajo M; Lucena-Agell D; Barasoain I; Díaz JF; Fang WS
    Eur J Med Chem; 2017 Sep; 137():488-503. PubMed ID: 28624703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells.
    Rong D; Wang C; Zhang X; Wei Y; Zhang M; Liu D; Farhan H; Momen Ali SA; Liu Y; Taouil A; Guo W; Wang Y; Ojima I; Yang S; Wang H
    Cancer Lett; 2020 Oct; 491():36-49. PubMed ID: 32730778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the new generation taxane anticancer agents.
    Geney R; Chen J; Ojima I
    Med Chem; 2005 Mar; 1(2):125-39. PubMed ID: 16787308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 1: Synthesis and biological activities of docetaxel analogues with a peptide side chain at C3'.
    Larroque AL; Dubois J; Thoret S; Aubert G; Guénard D; Guéritte F
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4722-6. PubMed ID: 16165352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Novel 3'-Difluorovinyl Taxoids.
    Kuznetsova L; Sun L; Chen J; Zhao X; Seitz J; Das M; Li Y; Veith JM; Pera P; Bernacki RJ; Xia S; Horwitz SB; Ojima I
    J Fluor Chem; 2012 Nov; 143():177-188. PubMed ID: 23139432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives.
    Larroque AL; Dubois J; Thoret S; Aubert G; Chiaroni A; Guéritte F; Guénard D
    Bioorg Med Chem; 2007 Jan; 15(1):563-74. PubMed ID: 17064914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
    Ojima I; Borella CP; Wu X; Bounaud PY; Oderda CF; Sturm M; Miller ML; Chakravarty S; Chen J; Huang Q; Pera P; Brooks TA; Baer MR; Bernacki RJ
    J Med Chem; 2005 Mar; 48(6):2218-28. PubMed ID: 15771464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents.
    Kuznetsova L; Chen J; Sun L; Wu X; Pepe A; Veith JM; Pera P; Bernacki RJ; Ojima I
    Bioorg Med Chem Lett; 2006 Feb; 16(4):974-7. PubMed ID: 16298526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the chemistry and biology of new generation taxoids.
    Ojima I; Das M
    J Nat Prod; 2009 Mar; 72(3):554-65. PubMed ID: 19239240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of C2-C3'N-linked macrocyclic taxoids. Novel docetaxel analogues with high tubulin activity.
    Querolle O; Dubois J; Thoret S; Roussi F; Guéritte F; Guénard D
    J Med Chem; 2004 Nov; 47(24):5937-44. PubMed ID: 15537348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of new second-generation taxoids.
    Ojima I; Wang T; Miller ML; Lin S; Borella CP; Geng X; Pera P; Bernacki RJ
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3423-8. PubMed ID: 10617084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.
    He Z; Schulz A; Wan X; Seitz J; Bludau H; Alakhova DY; Darr DB; Perou CM; Jordan R; Ojima I; Kabanov AV; Luxenhofer R
    J Control Release; 2015 Jun; 208():67-75. PubMed ID: 25725361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate-taxoid conjugate.
    Seitz JD; Vineberg JG; Herlihy E; Park B; Melief E; Ojima I
    Bioorg Med Chem; 2015 May; 23(9):2187-94. PubMed ID: 25819334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel larotaxel analogues.
    Ren S; Wang Y; Wang J; Gao D; Zhang M; Ding N; Li Y
    Eur J Med Chem; 2018 Aug; 156():692-710. PubMed ID: 30036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
    Ojima I; Geng X; Lin S; Pera P; Bernacki RJ
    Bioorg Med Chem Lett; 2002 Feb; 12(3):349-52. PubMed ID: 11814794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids.
    Kuznetsova LV; Pepe A; Ungureanu IM; Pera P; Bernacki RJ; Ojima I
    J Fluor Chem; 2008; 129(9):817-828. PubMed ID: 19448839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
    Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
    J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.